Viking Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 9.98 M | $351.25 M | -0.15% | 8.86% |
| BLACKROCK, INC. | 02/12/2026 | 6.61 M | $232.61 M | 18.15% | 5.87% |
| FMR LLC | 02/17/2026 | 6.56 M | $230.70 M | 13.26% | 5.75% |
| STATE STREET CORP | 02/13/2026 | 4.45 M | $156.39 M | -1.52% | 3.95% |
| MORGAN STANLEY | 02/13/2026 | 3.08 M | $108.22 M | -17.51% | 2.73% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 2.98 M | $104.80 M | 50.81% | 2.64% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 2.44 M | $85.69 M | 16.79% | 2.16% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 2.13 M | $74.91 M | 36.92% | 1.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.99 M | $70.18 M | 23.99% | 1.77% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.73 M | $60.95 M | -8.74% | 1.54% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.72 M | $60.46 M | 965.03% | 1.51% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.56 M | $54.76 M | -12.18% | 1.38% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.50 M | $52.81 M | 89.10% | 1.34% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.44 M | $50.50 M | 13.24% | 1.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.42 M | $50.09 M | -32.18% | 1.26% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 1.34 M | $47.11 M | -36.02% | 1.17% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 992.70 K | $34.92 M | 535.09% | 0.88% |
| CITADEL ADVISORS LLC | 02/17/2026 | 935.60 K | $32.91 M | -24.10% | 0.83% |
| UBS GROUP AG | 01/29/2026 | 934.93 K | $32.89 M | -30.35% | 0.83% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 922.00 K | $32.44 M | -3.38% | 0.81% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 832.65 K | $29.29 M | 210.99% | 0.74% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 752.73 K | $26.48 M | -37.08% | 0.67% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 722.20 K | $25.41 M | 253.69% | 0.64% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 719.37 K | $25.31 M | 392.11% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 700.30 K | $24.64 M | 0.37% | 0.61% |
| DIADEMA PARTNERS LP | 02/17/2026 | 688.90 K | $24.24 M | 70.06% | 0.61% |
| JANE STREET GROUP, LLC | 02/12/2026 | 636.00 K | $22.37 M | -9.85% | 0.57% |
| BLACKBARN CAPITAL PARTNERS LP | 02/17/2026 | 550.00 K | $19.35 M | 10.00% | 0.49% |
| JPMORGAN CHASE & CO | 02/11/2026 | 546.83 K | $19.24 M | -78.78% | 0.49% |
| NORTHERN TRUST CORP | 02/17/2026 | 541.05 K | $19.03 M | -2.91% | 0.47% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 518.80 K | $18.25 M | -4.67% | 0.46% |
| BARCLAYS PLC | 02/13/2026 | 516.66 K | $18.18 M | 12.12% | 0.46% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 513.73 K | $18.07 M | -0.05% | 0.46% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 500.00 K | $17.59 M | -42.53% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 474.62 K | $16.70 M | -5.04% | 0.42% |
| ROYAL BANK OF CANADA | 02/17/2026 | 455.42 K | $16.02 M | -29.75% | 0.40% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 459.58 K | $16.17 M | -2.48% | 0.40% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 444.84 K | $15.65 M | 0.14% | 0.39% |
| BLAIR WILLIAM & CO/IL | 02/17/2026 | 423.96 K | $14.92 M | 19.12% | 0.38% |
| FIRST WASHINGTON CORP | 02/13/2026 | 387.53 K | $13.63 M | 45.23% | 0.34% |
| WALLEYE TRADING LLC | 02/13/2026 | 389.80 K | $13.71 M | -2.21% | 0.34% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 346.65 K | $12.20 M | -40.05% | 0.31% |
| DIADEMA PARTNERS LP | 02/17/2026 | 336.85 K | $11.85 M | 73.91% | 0.30% |
| STIFEL FINANCIAL CORP | 02/13/2026 | 336.82 K | $11.85 M | -3.87% | 0.30% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 330.10 K | $11.61 M | 100.00% | 0.29% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 326.40 K | $11.47 M | 1,532.00% | 0.29% |
| DIADEMA PARTNERS LP | 02/17/2026 | 316.70 K | $11.14 M | 100.00% | 0.28% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 316.25 K | $11.13 M | 2.60% | 0.28% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 313.49 K | $11.03 M | 100.00% | 0.28% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 305.37 K | $10.74 M | 3.10% | 0.27% |
Viking Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 532 institutional investors and hedge funds held shares of Viking Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 1.35 M
Pictet Asset Management Holding SA: 696,301
PRINCIPAL FINANCIAL GROUP INC: 525,484
Bank of New York Mellon Corp: 454,063
Concurrent Investment Advisors, LLC: 347,786
WASATCH ADVISORS LP: 313,158
64.04% of Viking Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 82.14 M shares in the last 24 months. This purchase volume represents approximately $2.76 B in transactions.